Aoxing Pharmaceutical Company, Inc.

AOXG · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2016
6/30/2015
Operating Activities
Net Income-$15$2,061$5,495
Dep. & Amort.$0$1,026$666
Deferred Tax$0$642-$2,704
Stock-Based Comp.$0$0$0
Change in WC$15-$5,527-$805
Other Non-Cash-$15$471$494
Operating Cash Flow-$15-$535$3,026
Investing Activities
PP&E Inv.$0-$118-$2,705
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0-$118-$2,705
Financing Activities
Debt Repay.$0$207$249
Stock Issued$0$2,739$2,424
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$15$0$0
Financing Cash Flow$15$2,946$2,673
Forex Effect$0-$753$49
Net Chg. in Cash$0$1,541$3,042
Supplemental Information
Beg. Cash$0$5,372$2,330
End Cash$0$6,912$5,372
Free Cash Flow-$15-$653$320